Arvinas (ARVN) Receivables - Net (2017 - 2026)
Arvinas (ARVN) recorded quarterly Receivables - Net of $1.8 million in Q1 2026, up 80.0% quarter-over-quarter from $1.0 million in Q4 2025, and up 350.0% on a YoY basis from $400000.0 in Q1 2025.
Arvinas (ARVN) Receivables - Net (2017 - 2026) Analysis & Trends
Arvinas' Receivables - Net history runs 10 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 350.0% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 350.0% YoY), while the FY2025 annual figure was $1.0 million, down 82.46% from the prior year.
- Receivables - Net was $1.8 million for Q1 2026 at Arvinas, up from $1.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $20.3 million in Q3 2025 to a low of $100000.0 in Q2 2023.
- Historically, Receivables - Net has averaged $4.5 million across 5 years, with a median of $1.4 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Receivables - Net tumbled 93.33% in 2022, then soared 1700.0% in 2024.
- A 5-year view of Receivables - Net shows it stood at $1.0 million in 2022, then surged by 1470.0% to $15.7 million in 2023, then slumped by 63.69% to $5.7 million in 2024, then tumbled by 82.46% to $1.0 million in 2025, then jumped by 80.0% to $1.8 million in 2026.
- The last three Receivables - Net figures came in at $1.8 million (Q1 2026), $1.0 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80 Mn |
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 20.30 Mn |
| Sep 30, 2025 | 20.30 Mn |
| Jun 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 5.70 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 7.30 Mn |
| Sep 30, 2024 | 7.30 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Sep 30, 2023 | 15.70 Mn |
| Sep 30, 2023 | 15.70 Mn |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |